Protective effect of geranylgeranylacetone on trinitrobenzene sulfonic acid-induced colitis in mice

International Journal of Molecular Medicine

Volumn 17, Issue 2, 2006, Pages 229-234

  Ohkawara, Tatsuya ^a,b   Nishihira, Jun ^b   Takeda, Hiroshi ^a   Katsurada, Takehiko ^a   Kato, Kanji ^a   Yoshiki, Takashi ^b   Sugiyama, Toshiro ^c   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GeneticLab Co Ltd   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Colitis; Geranylgeranylacetone; Heat shock protein; Inflammatory bowel disease; Trinitrobenzene sulfonic acid

Indexed keywords

DITERPENE; HEAT SHOCK PROTEIN 70; PEROXIDASE; TEPRENONE; TRINITROBENZENESULFONIC ACID;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; CD4+ T LYMPHOCYTE; CHEMICALLY INDUCED DISORDER; COLITIS; DRUG EFFECT; MALE; METABOLISM; MOUSE; ORGAN SIZE; PATHOLOGY; SURVIVAL RATE;

ANIMALS; BODY WEIGHT; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DITERPENES; HSP70 HEAT-SHOCK PROTEINS; MALE; MICE; MICE, INBRED BALB C; ORGAN SIZE; PEROXIDASE; SURVIVAL RATE; TRINITROBENZENESULFONIC ACID;

EID: 33644854119     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.2.229     Document Type: Article

References (38)

1. Podolsky DK: Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
2. Sartor RB: Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92 (suppl 12): 5S-11S, 1997.
3. Papadakis KA and Targan SR: Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51: 289-298, 2000. (Pubitemid 30216038)
4. Ohkawara T, Nishihira J, Takeda H, Hige S, Kato M, Sugiyama T, Iwanaga T, Nakamura H, Mizue Y and Asaka M: Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 123: 256-270, 2002.
5. Van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN and Woody J: Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109: 129-135, 1995.
6. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, De Woody KL, Schaible TF and Rutgeerts PJ: A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337: 1029-1035, 1997.
7. Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB and Cominelli F: The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology 117: 1433-1437, 1999.
8. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN and Braun MM: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098-1104, 2001.
9. Terano A, Shiga J, Hiraishi H, Ota S and Sugimoto T: Protective action of tetraprenylacetone against ethanol-induced damage in rat gastric mucosa. Digestion 35: 182-188, 1986. (Pubitemid 16001679)
10. Murakami M, Oketani K, Fujisaki H, Wakabayashi T, Ohgo T and Okabe S: Effects of the antiulcer drug geranylgeranylacetone on aspirin-induced gastric ulcers in rats. Jpn J Pharmacol 32: 299-306, 1982.
11. Oketani K, Murakami M, Fujisaki H, Wakabayashi T and Hotta K: Effect of geranylgeranylacetone on aspirin-induced changes in gastric glycoproteins. Jpn J Pharmacol 33: 593-601, 1983.
12. Fujimono M, Yamanaka T, Bessho M and Igarashi T: Effects of geranylgeranylacetone on gastrointestinal secretion in rats. Eur J Pharmacol 77: 113-118, 1982. (Pubitemid 12213596)
13. Hirakawa T, Rokutan K, Nikawa T and Kishi K: Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 111: 345-357, 1996. (Pubitemid 26256722)
14. Ooie T, Takahashi N, Saikawa T, Nawata T, Arikawa M, Yamanaka K, Hara M, Shimada T and Sakata T: Single oral of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation 104: 1873-1843, 2001.
15. Oda H, Miyake H, Iwata T, Kusumoto K, Rokutan K and Tashiro S: Geranylgeranylacetone suppresses inflammatory responses and improves survival after massive hepatectomy in rats. J Gastrointest Surg 6: 464-472, 2002.
16. Masuda Y, Sumita S, Fujimura N and Namiki A: Geranylgeranylacetone attenuates septic diaphragm dysfunction by induction of heat shock protein 70. Crit Care Med 31: 2585-2591, 2003.
17. Hightower LE: Heat shock, stress proteins, chaperones and proteotoxicity. Cell 66: 191-197, 1991. (Pubitemid 121001359)
18. Nakamura K, Rokutan K, Marui N, Aoike A and Kawai K: Induction of heat shock proteins and their implication in protection against ethanol-induced damage in cultured guinea pig gastric mucosal cells. Gastroenterology 101: 161-166, 1991.
19. Mestril R, Chi SH, Sayen MR, O'Reilly K and Dillmann WH: Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against stimulated ishemia-induced injury. J Clin Invest 93: 759-767, 1994.
20. Fujimori S, Otaka M, Otani S, Jin M, Okuyama A, Itoh S, Iwabuchi A, Sasahara H, Itoh H, Tashima Y, Komatsu M and Masamune O: Induction of a 72-kDa heat shock protein and cytoprotection against thioacetamide-induced liver injury in rats. Dig Dis Sci 42: 1987-1994, 1997.
21. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM and Dillmann WH: Overexpression of the rat inducible 70-kDa heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 95: 1446-1456, 1995.
22. Hutter JJ, Mestril R, Tam EK, Sievers RE, Dillmann WH and Wolfe CL: Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation 94: 1408-1411, 1996.
23. Ludwig D, Stahl M, Ibrahim ET, Wenzel BE, Drabicki D, Wecke A, Fellermann K and Stange EF: Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases. Dig Dis Sci 44: 1440-1447, 1999.
24. Otani S, Otaka M, Jin M, Okuyama A, Itoh S, Iwabuchi A, Sasahara H, Itoh H, Tashima Y and Masamune O: Effect of preinduction of heat shock proteins on acetic acid-induced colitis in rats. Dig Dis Sci 42: 833-846, 1997. (Pubitemid 27196039)
25. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H and McGhee JR: Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 189: 1169-1180, 1999.
26. Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A and Strober W: Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 117: 1078-1088, 1999.
27. Ohkawara T, Miyashita K, Nishihira J, Mitsuyama K, Takeda H, Kato M, Kondo N, Yamasaki Y, Sata M, Yoshiki T, Sugiyama T and Asaka M: Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis. Clin Exp Immunol 140: 241-248, 2005.
28. Elson CO, Sartor RB, Tennyson GS and Riddell RH: Experimental model of inflammatory bowel disease. Gastroenterology 109: 1344-1367, 1995.
29. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR and Wallace JL: Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803, 1989.
30. Pender SL, Chance V, Whiting CV, Buckley M, Edwards M, Pettipher R and MacDonald TT: Systemic administration of the chemokine macrophage inflammatory protein 1 alpha exacerbates inflammatory bowel disease in a mouse model. Gut 54: 1114-1120, 2005.
31. Nishida K, Ohta Y and Ishiguro I: Protective and preventive effects of teprenone on gastric mucosal lesions in rats. Eur J Pharmacol 354: 51-58, 1998. (Pubitemid 28410230)
32. Tomisato W, Takahashi N, Komoto C, Rokutan K, Tsuchiya T and Mizushima T: Geranylgeranylacetone protects cultured guinea pig gastric mucosal cells from indomethacin. Dig Dis Sci 45: 1674-1679, 2000.
33. Krawisz JE, Sharon P and Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350, 1984.
34. Yoshimura N, Suzuki Y and Saito Y: Suppression of Helicobacter pylori-induced interleukin-8 production in gastric cancer cell lines by an anti-ulcer drug, geranylgeranylacetone. J Gastroenterol Hepatol 17: 1153-1160, 2002.
35. Miyake K, Tsukui T, Shinji Y, Shinoki K, Hiratsuka T, Nishigaki H, Futagami S, Wada K, Gudis K, Iwakiri K, Yamada N and Sakamoto C: Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines. Helicobacter 9: 130-137, 2004.
36. Ikeyama S, Kusumoto K, Miyake H, Rokutan K and Tashiro S: A non-toxic heat shock protein 70 inducer, geranylgeranylacetone, suppresses apoptosis of cultrured rat hepatocytes caused by hydrogen peroxide and ethanol. J Hepatol 35: 53-61, 2001.
37. Lee SH, Kwon HM, Kim YJ, Lee KM, Kim M and Yoon BW: Effects of hsp70.1 gene knockout on the mitochondrial apoptotic pathway after focal cerebral ischemia. Stroke 35: 2195-2199, 2004.
38. Ohkawara T, Nishihira J, Takeda H, Miyashita K, Kato K, Kato M, Sugiyama T and Asaka M: Geranylgeranylacetone protects mice from dextran sulfate sodium-induced colitis. Scand J Gastroenterol 40: 1049-1057, 2005.